OncoSenX
Seattle
About OncoSenX
OncoSenX is a developer of transient gene therapies designed for solid tumors. The company's therapy delivers plasmid DNA with a novel lipid nanoparticle that selectively kills cancerous cells based on their transcriptional activity, providing cancer patients, doctors and medical care professionals with a less invasive and more precise intervention for this complex and devastating disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $11.7M
- Funding stage: Seed
- Last round: Seed (Jan 2021)
- Website: oncosenx.com
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/oncosenx-63546 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.